Clinical Trials Directory

Trials / Sponsors / AnaptysBio, Inc.

AnaptysBio, Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Ulcerative Colitis
Phase 22023-12-04
Active Not RecruitingA Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)
Rheumatoid Arthritis
Phase 22023-08-31
TerminatedThis Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe
Atopic Dermatitis Eczema
Phase 22023-06-13
UnknownA Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-S
Alopecia Areata
Phase 22021-12-22
CompletedEtokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Chronic Rhinosinusitis
Phase 22018-11-29
CompletedEfficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Seve
Atopic Dermatitis
Phase 22018-06-19
CompletedProof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophili
Eosinophilic Asthma
Phase 22017-11-14
CompletedStudy to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy
Peanut Allergy
Phase 22017-01-26